Sign Up
    OverviewAPI
    Bioventus Inc. faces investigation for potential claims against long-term stockholders due to allegations of breach of fiduciary duties by the board of directors. The company is accused of negligently prepared and misleading statements in its Offering Documents, leading to significant losses for investors. Bragar Eagel & Squire, P.C. is representing individual and institutional investors in complex litigation.

    Ask a question